In the case of KIRP we observed six TFs exhibiting promoter hypermethylation at over 20 % of the tumours with underexpression of the TF, in contrast to no TF exhibiting CNV loss at that frequency or higher (Fig. 5a). This evidence concerns the gene TF and neoplasm.